Anti-(human Cd20 Antigen) (human-mus Musculus Monoclonal Disulfide Sct400 .gamma.1-chain)
Anti-(human Cd20 Antigen) (human-mus Musculus Monoclonal Disulfide Sct400 .gamma.1-chain) Uses, Dosage, Side Effects, Food Interaction and all others data.
Anti-(human Cd20 Antigen) (human-mus Musculus Monoclonal Disulfide Sct400 .gamma.1-chain) is under investigation in clinical trial NCT02772822 (A Study Comparing the Efficiency and Safety of S-chop(cyclophosphamide, Hydroxydaunomycin, Oncovin, and Prednisone) Versus R-CHOP in Untreated Cd20(cluster of Differentiation Antigen 20)-positive DLBCL Patients).
| Trade Name | Anti-(human Cd20 Antigen) (human-mus Musculus Monoclonal Disulfide Sct400 .gamma.1-chain) |
| Generic | Ripertamab |
| Ripertamab Other Names | Immunoglobulin g1-kappa, anti-(homo sapiens ms4a1 (membrane-spanning 4-domains subfamily a member 1, cd20)), chimeric monoclonal antibody, Immunoglobulin igg1, anti-(human cd20 antigen) (human-mus musculus monoclonal disulfide sct400 .gamma.1-chain), disulfide with human-mus musculus monoclonal sct400 .kappa.-chain, dimer, Ripertamab |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Anti-(human Cd20 Antigen) (human-mus Musculus Monoclonal Disulfide Sct400 .gamma.1-chain)
